Background: To explore the value of chemoradiotherapy (CRT) in stage II nasopharyngeal
carcinoma (NPC) compared to radiotherapy (RT) alone which includes two-dimensional …

Nasopharyngeal carcinoma (NPC) is one of the most common malignant tumors of the head
and neck, and it originates from the mucous epithelium of the nasopharynx. Because it is …

Objectives The subgroups of patients with nasopharyngeal carcinoma (NPC) who benefit
from induction chemotherapy plus concurrent chemoradiotherapy (IC+ CCRT) remain …

Nasopharyngeal carcinoma (NPC) is a rare type of head and neck cancer, with a higher
incidence reported only in Southeast Asia and Northern Africa. Owing to the rarity of NPC …

Objectives To establish and validate an effective nomogram to predict clinical outcomes for
patients with locoregionally advanced nasopharyngeal carcinoma (LA-NPC). Materials and …

The TNM staging system of NPC is the most important model for survival prediction.
However, this model does not consider the biological variability of the tumor itself. This study …

Concurrent chemoradiotherapy is the established treatment for locally advanced
nasopharyngeal carcinoma (NPC). However, there is no evidence supporting routine …

Background Concurrent chemoradiotherapy followed by adjuvant chemotherapy (CCRT-
AC) is currently recommended as the standard treatment for locally advanced …

Background We investigated the survival impact and toxicity of maintenance metronomic
chemotherapy in patients with metastatic/recurrent nasopharyngeal carcinoma (met/rec …

Background Our study assessed post‐radiation therapy (RT) G‐tube presence, duration,
and clinical predictors in patients with head and neck cancer (HNC). Methods We identified …